|
Myeloid Neoplasia
Citations 1-10 of 166 total displayed.
|
Most recent content
(5 Nov 2009):
|
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal
- Michael Heuser, Laura M. Sly, Bob Argiropoulos, Florian Kuchenbauer, Courteney Lai, Andrew Weng, Malina Leung, Grace Lin, Christy Brookes, Stephen Fung, Peter J. Valk, Ruud Delwel, Bob Löwenberg, Gerald Krystal, and R. Keith Humphries
Blood 2009; 114: 3983-3993.
[Abstract]
[Full text]
[PDF]
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse
- Francis Giles, Norbert Vey, Daniel DeAngelo, Karen Seiter, Wendy Stock, Robert Stuart, Darinka Boskovic, Arnaud Pigneux, Martin Tallman, Joseph Brandwein, Jonathan Kell, Tadeusz Robak, Peter Staib, Xavier Thomas, Ann Cahill, Maher Albitar, and Susan O'Brien
Blood 2009; 114: 4027-4033.
[Abstract]
[Full text]
[PDF]
BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38– cells, through activation of protein kinase Cβ
- Francesca Pellicano, Mhairi Copland, Heather G. Jorgensen, Joanne Mountford, Brian Leber, and Tessa L. Holyoake
Blood 2009; 114: 4186-4196.
[Abstract]
[Full text]
[PDF]
E3 ligase–defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease
- Srinivasa Rao Bandi, Christian Brandts, Marion Rensinghoff, Rebekka Grundler, Lara Tickenbrock, Gabriele Köhler, Justus Duyster, Wolfgang E. Berdel, Carsten Müller-Tidow, Hubert Serve, on behalf of the Study Alliance Leukemias, and Bülent Sargin
Blood 2009; 114: 4197-4208.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Jan 2009):
|
How I treat hypereosinophilic syndromes
- Amy D. Klion
Blood 2009; 114: 3736-3741.
[Abstract]
[Full text]
[PDF]
Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
- Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin-Yang Li, and Ayalew Tefferi
Blood 2009; 114: 3769-3772.
[Abstract]
[Full text]
[PDF]
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
- Qing Zhou, Christoph Bucher, Meghan E. Munger, Steven L. Highfill, Jakub Tolar, David H. Munn, Bruce L. Levine, Megan Riddle, Carl H. June, Daniel A. Vallera, Brenda J. Weigel, and Bruce R. Blazar
Blood 2009; 114: 3793-3802.
[Abstract]
[Full text]
[PDF]
Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome
- Britta Will, Masahiro Kawahara, Julia P. Luciano, Ingmar Bruns, Samir Parekh, Connie L. Erickson-Miller, Manuel A. Aivado, Amit Verma, and Ulrich Steidl
Blood 2009; 114: 3899-3908.
[Abstract]
[Full text]
[PDF]
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
- Rifca Le Dieu, David C. Taussig, Alan G. Ramsay, Richard Mitter, Faridah Miraki-Moud, Rewas Fatah, Abigail M. Lee, T. Andrew Lister, and John G. Gribben
Blood 2009; 114: 3909-3916.
[Abstract]
[Full text]
[PDF]
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
- Luca Malcovati, Matteo G. Della Porta, Daniela Pietra, Emanuela Boveri, Andrea Pellagatti, Anna Gallì, Erica Travaglino, Angela Brisci, Elisa Rumi, Francesco Passamonti, Rosangela Invernizzi, Laura Cremonesi, Jacqueline Boultwood, James S. Wainscoat, Eva Hellström-Lindberg, and Mario Cazzola
Blood 2009; 114: 3538-3545.
[Abstract]
[Full text]
[PDF]
|
|
